Skip to main content

Articles

Page 147 of 148

  1. Destruction of cartilage and bone are hallmarks of human rheumatoid arthritis (RA), and controlling these erosive processes is the most challenging objective in the treatment of RA. Systemic interleukin-4 trea...

    Authors: Leo AB Joosten, Erik Lubberts, Monique MA Helsen, Tore Saxne, Christina JJ Coenen-de Roo, Dick Heinegård and Wim B van den Berg
    Citation: Arthritis Research & Therapy 1999 1:81
  2. Our aim was to identify specifically expressed genes using RNA arbitrarily primed (RAP)-polymerase chain reaction (PCR) for differential display in patients with rheumatoid arthritis (RA). In RA, amplification...

    Authors: Frank Kullmann, Martin Judex, Wibke Ballhorn, Hans-Peter Jüsten, Dieter Wessinghage, John Welsh, Tim J Yen, Bernhard Lang, Jim C Hittle, Michael McClelland, Steffen Gay, Jürgen Schölmerich and Ulf Müller-Ladner
    Citation: Arthritis Research & Therapy 1999 1:71
  3. The genetic basis for rheumatoid arthritis (RA) is likely to be extremely complex. Even the role of MHC genes remains to be fully defined, and may involve interactive genetic effects. The difficulty of precise...

    Authors: Peter K Gregersen
    Citation: Arthritis Research & Therapy 1999 1:37
  4. The biologically active metabolite of vitamin D3, 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3], acts through vitamin D receptors, which were found in rheumatoid tissues in the present study. IL-1β-activated rheumatoi...

    Authors: Lynne C Tetlow and David E Woolley
    Citation: Arthritis Research & Therapy 1999 1:63

Annual Journal Metrics